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Abstract 11 
The growing demand for wines with a more pronounced aromatic profile calls for low 12 
temperature alcoholic fermentations (10 – 15 ºC). However, there are certain drawbacks 13 
to low temperature fermentations such as reduced growth rate, long lag phase and 14 
sluggish or stuck fermentations. The lipid metabolism of Saccharomyces cerevisiae 15 
plays a central role in low temperature adaptation. The aim of this study was to detect 16 
lipid metabolism genes involved in cold adaptation. To do so, we analyzed the growth 17 
of knockouts in phospholipids, sterols and sphingolipids, from the EUROSCARF 18 
collection Saccharomyces cerevisiae BY4742 strain at low and optimal temperatures. 19 
Growth rate of these knockouts, compared with the control, enabled us to identify the 20 
genes involved, which were also deleted or overexpressed in a derivative haploid of a 21 
commercial wine strain. We identified genes involved in the phospholipid (PSD1 and 22 
OPI3), sterol (ERG3 and IDI1) and sphingolipid (LCB3) pathways, whose deletion 23 
strongly impaired growth at low temperature and whose overexpression reduced 24 
generation or division time by almost half. Our study also reveals many phenotypic 25 
differences between the laboratory strain and the commercial wine yeast strain, showing 26 
the importance of constructing mutant and overexpressing strains in both genetic 27 
backgrounds. The phenotypic differences in the mutant and overexpressing strains were 28 
correlated with changes in their lipid composition.   29 
 30 
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1. Introduction 33 
Temperature fluctuations are an inevitable part of microbial life in exposed natural 34 
environments; however, sub-optimal temperatures are also common in industrial 35 
processes. Low temperatures (10-15 ºC) are used in wine fermentations to enhance 36 
production and retain flavor volatiles. In this way, white and rosé wines of greater 37 
aromatic complexity can be achieved (Beltran et al., 2008; Torija et al., 2003). The 38 
optimum fermentation temperature for Saccharomyces is between 25 and 28 ºC. 39 
Therefore, among the difficulties inherent to wine fermentation (high concentration of 40 
sugars, low pH, presence of ethanol, nutrient deficiency, etc.), we should add a sub-41 
optimal temperature for the primary fermentation agent. Temperature affects both yeast 42 
growth and fermentation rate, with lower temperatures giving rise to a very long latency 43 
phase of up to one week or longer and sluggish fermentations (Bisson, 1999; Meurgues, 44 
1996), dramatically lengthening alcoholic fermentation with the consequent energy 45 
expenditure.  46 
Low temperature has several effects on biochemical and physiological properties in 47 
yeast cells: low efficiency of protein translation, low fluidity membrane, change in lipid 48 
composition, slow protein folding, stabilization of mRNA secondary structures and 49 
decrease in enzymatic activities (Aguilera et al., 2007; Hunter and Rose, 1972; Sahara 50 
et al., 2002; Schade et al., 2004). To date, most studies have mainly focused on the 51 
genome-wide transcriptional responses to cold-shock (Beltran et al., 2006; Homma et 52 
al., 2003; Murata et al., 2006; Sahara et al., 2002; Schade et al., 2004). In a decisive 53 
study, Tai et al. (2007) compared their transcriptomic results obtained in a steady-state 54 
chemostat culture with other previous genome-wide transcriptional studies of batch 55 
cultures at low temperature. Interestingly, lipid metabolism genes were the only ones 56 
whose activity was clearly regulated by low temperature. This is consistent with the 57 
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notion that after a temperature downshift, homeoviscous adaptation of the membrane 58 
composition is essential for growth (Beltran et al., 2006; Beltran et al., 2007; Hunter 59 
and Rose, 1972; Torija et al., 2003). 60 
Biological membranes are the first barrier between the cell interior and its environment 61 
and a primary target for damage during cold stress. Major lipid components of 62 
eukaryotic membranes are phospholipids, sterols, sphingolipids and glycerolipids. The 63 
main species of fatty acids of S. cerevisiae are C16 and C18, with or without a double 64 
bond. The composition of these lipid components is important for the physical 65 
properties of the membrane, such as fluidity. Incubation at low temperature increases 66 
the molecular order of membrane lipids by rigidification (Russell, 1990). Yeasts are 67 
known to have developed several strategies to maintain appropriate membrane fluidity. 68 
The most commonly studied involves the increase in unsaturation (mainly palmitoleic 69 
C16:1 and oleic C18:1 acids). Phospholipids with unsaturated fatty acids (UFA) have a 70 
lower melting point and greater flexibility than phospholipids with saturated acyl 71 
chains. Another way of increasing membrane lipid fluidity is to decrease the chain 72 
length (ChL) of these FA by increasing the synthesis of medium chain fatty acids 73 
(MCFA; C6 to C14) (Beltran et al., 2008; Torija et al., 2003). Recently, Redón et al. 74 
(2011) also reported new common changes in the lipid composition of different 75 
industrial species and strains of Saccharomyces after low temperature growth.  Despite 76 
specific strains/species dependent responses, the results showed that at low temperatures 77 
the MCFA and triacylglyceride (TG) content increased, whereas the phosphatidic acid 78 
content (PA) and the phosphatidylcholine/phosphatidylethanolamine (PC/PE) ratio 79 
decreased. 80 
Reshaping the plasma membrane composition might be a good strategy for adapting 81 
yeast cells to low temperatures, reducing the lag-phase and speeding up fermentation 82 
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onset. In this respect, knock-out or overexpression of genes related with lipid 83 
metabolism can modify the architecture of this plasma membrane. In a preliminary 84 
study (Redón et al., 2012), we tested various phospholipid mutants from the 85 
EUROSCARF collection of S. cerevisiae BY4742 to ascertain whether the suppression 86 
of some genes could improve the fermentation vitality of the cells at low temperature. 87 
The aim of this study was to detect key genes in the lipid metabolism pathways which 88 
play an important role in the adaptation of S. cerevisiae to low temperature. To achieve 89 
this objective, we analyzed the growth of several knockouts of phospholipid, sterol and 90 
sphingolipid pathways at 12 ºC and 28 ºC and compared them to the wild type BY4742. 91 
This first screening of the laboratory strain enabled us to select genes for deletion and 92 
overexpression in the genetic background of a derivative haploid of the commercial 93 
wine strain, QA23. The phenotypic differences in the mutant and overexpressing strains 94 
were correlated with the changes in their lipid composition.   95 
  96 
2. Material and methods 97 
2.1 Strains and growth media  98 
S. cerevisiae strains used in this study were: a total of 34 phospholipid, sterol and 99 
sphingolipid mutants of the laboratory strain BY4742 (MATα, his3Δ 1; leu2Δ 0; lys2Δ 100 
0; ura3Δ 0), from the EUROSCARF collection (Frankfurt, Germany) and the derivative 101 
haploid of the commercial wine strain QA23 (Lallemand S.A., Canada), hoQA23 102 
(Salvado et al., 2012). 103 
These strains were cultured on SC (6.7 g/L Difco Yeast Nitrogen Base (w/o amino 104 
acids), 20 g/L glucose, 0.83 g/L synthetic complete drop-out mix (2 g Histidine, 4 g 105 
Leucine, 2 g Lysine 1.2 g Uracil)). They were grown in Erlenmeyer flasks (250 mL) 106 
filled with 50 mL of medium, fitted with cotton and shaken at 200 rpm at 30 ºC for 48 107 
 6 
hours. The population inoculated in every flask was 2 x 10
6
 cells/mL from an overnight 108 
culture in YPD at 30 ºC. 109 
 110 
2.2 Construction of mutant and overexpressing strains 111 
Mutated genes which showed growth insufficiency in the background of the laboratory 112 
strain BY4742 were deleted on the derivative haploid of a commercial wine strain, 113 
hoQA23. Genes were deleted using the short flanking homology (SFH) method based 114 
on the KanMX4 deletion cassette (Güldener et al., 1996). The primers used for 115 
amplification of the loxP-KanMX4-loxP cassette from the plasmid pUG6 have 50-116 
nucleotide extensions corresponding to regions upstream of the target gene start codon 117 
(forward primer) and downstream of the stop codon (reverse primer). The PCR 118 
fragments were used to transform the haploid hoQA23 strain using the lithium acetate 119 
procedure (Gietz et al., 2002). After transformation, strain selection was done using 120 
Geneticin (G418) added to YPD solid media at a concentration of 200 mg/L. Total 121 
DNA from transformants resistant to G418 Geneticin was analyzed by PCR using 122 
primers upstream and downstream of the deleted region combined with primers of the 123 
KanMX gene. 124 
 The genes, whose deletion significantly impaired growth in the hoQA23, were 125 
overexpressed by cloning into the centromeric plasmid pGREG505, as described in 126 
Jansen et al. (2005). All genes were amplified from approximately 600 nucleotides 127 
upstream of the start codon to 400 nucleotides downstream of the stop codon to ensure 128 
that the promoter and terminator regions were included. The PCR protocol involved an 129 
initial denaturation at 94 ºC (2 min), followed by 30 cycles of 10 s at 94 ºC, 30 s at 49-130 
50 ºC (depending on the different primers) and 3-4 min at 72 ºC (depending on the 131 
different PCR product length). The last cycle was followed by a final extension step of 132 
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10 min at 72 ºC. PCR fragments were generated with oligonucleotides that contained 133 
the short sequences rec5 (forward) and rec2 (reverse), which are homologous to the 134 
sequences in the plasmid (about 35 bp). The plasmid was linearized by SalI digestion 135 
and digested with AslI to avoid sticky ends and to make the recombination process 136 
easier (Jansen et al., 2005). The wine yeast hoQA23 was co-transformed with the 137 
digested pGREG505 plasmid together with the PCR amplified target gene, flanked by 138 
recombination sequences homologues to the plasmid ends. This co-transformation 139 
promotes an in vivo homologous recombination between both fragments. This 140 
recombination process also deleted the GAL1 promoter of the plasmid (the genes were 141 
cloned with their own promoters). The transformants were selected by Geneticin 142 
resistance, which is encoded by the KanMX gene in the plasmid. Correct yeast 143 
transformations were verified by plasmid DNA isolation using a modification of the 144 
protocol described by Robzyk and Kassir (1992) and subsequently amplification with 145 
the Illustra TempliPhi Amplification Kit (GE Healthcare, UK). Then, to verify the 146 
correct integration of the gene into the vector, plasmids were checked by PCR using 147 
primers specified for sequences rec5 and rec2. All the strains (mutants and 148 
overexpressing) constructed in this study are shown in Table 1. 149 
 150 
2.3 Generation time (GT) 151 
Growth was monitored at 600 nm in a SPECTROstar Omega instrument (BMG 152 
Labtech, Offenburg, Germany) at 12 ºC and 28 ºC. Measurements were taken, after pre-153 
shaking the microplate for 20 s, every half hour over 3 days. However at 12 ºC the 154 
microplate had to be incubated outside the SPECTROstar spectrophotometer and then 155 
transferred inside to take measurements every 8 hours during the lag phase and every 3 156 
hours during the exponential phase. The microplate wells were filled with 0.25 mL of 157 
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SC medium, reaching an initial OD of approximately 0.2 (inoculum level of 2 x 10
6
 158 
CFU/mL). Uninoculated wells for each experimental series were also included in the 159 
microplate to determine, and consequently subtract, the noise signal. All experiments 160 
were carried out in triplicate. 161 
 Growth parameters were calculated from each treatment by directly fitting OD 162 
measurements versus time to the reparameterized Gompertz equation proposed by 163 
Zwietering et al. (1990): 164 
 y=D*exp{-exp[((µmax*e)/D)*(λ-t))+1]}   165 
where y=ln(ODt/OD0), OD0 is the initial OD and ODt is the OD at time t; 166 
D=ln(ODt/OD0) is the asymptotic maximum, µmax is the maximum specific growth rate 167 
(h
-1), and λ the lag phase period (h) (Salvadó et al., 2011). Generation time (GT) was 168 
calculated using the equation GT=ln2/µmaxWe normalized this value by subtracting the 169 
GT of S. cerevisiae BY4742 and hoQA23 (control strains).  170 
171 
2.4 Spot test 172 
To analyze growth phenotypes of mutant strains, cells grown on SC to stationary phase 173 
(OD600 ~ 4) were harvested by centrifugation, washed with sterile water, resuspended 174 
in sterile water to an OD (600 nm) value of 0.5, followed by serial dilution of 10
-1
, 10
-2
, 175 
10
-3
 and 10
-4
. From each dilution, 3.5 L was spotted onto SC agar plates. The plates 176 
were incubated at 28 ºC and 12 ºC for 2-9 days. 177 
 178 
2.5 Lipid extraction 179 
Mutant and overexpressing strains were grown in SC for 48 hours at 28 ºC. Geneticin 180 
was also added (200 mg/L) to the SC medium of the overexpressing strains to stabilize 181 
the plasmid and promote overexpression of the genes. Cells were frozen until the 182 
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different lipid analyses. Prior to lipid extraction, a solution of 100 L of cold methanol 183 
and 20 L of EDTA 0.1 mM was added to the yeast cells (5-10 mg dry mass) with 1 g 184 
glass beads (0.5 mm, Biospec Products) in Eppendorf, and then mixed for 5 minutes in 185 
a mini-bead-beater-8 (Biospec Products, Qiagen). Lipid extraction was performed in 186 
two steps with 1 mL chloroform/methanol (2:1, v/v, for 1 hour), one step with 1 mL 187 
chloroform/methanol (1:1, v/v, for 1 hour) and one step with 1 mL chloroform/methanol 188 
(1:2, v/v, for 1 hour). All the organic phases were transferred to a 15 mL glass screw 189 
tube and cleaned twice by adding KCl 0.88% (1/4 of a total volume of the extract). 190 
After vortexing and cooling at 4 ºC for 10 minutes, the samples were centrifuged at 191 
3000 rpm for 5 minutes. The inferior organic phase was collected and finally 192 
concentrated to dryness under nitrogen stream. The residue was dissolve in 100 µL of 193 
chloroform/methanol (2:1, v/v). 194 
 195 
2.6 Separation and quantification of the yeast phospholipids (PLs) by HPTLC 196 
The yeast extract phospholipids were separated by one-dimensional HPTLC on silica 197 
gel 60F254 plates (10 x 20cm, 200 µm) with chloroform: acetone: methanol: glacial 198 
acetic acid: water (65:15:10:10:5, v/v/v/v/v). After charring the plate with 10% CuSO4 199 
in 8% H3PO4 and heating to 160 ºC for 4 min, the PLs were identified by known 200 
standards purchased from Sigma: phosphatidylinositol (PI), phosphatidylserine (PS), 201 
phosphatidylcholine (PC), phosphatidylglycerol (PG), phosphatidylethanolamine (PE), 202 
cardiolipin (CL) and phosphatidic acid (PA). The plates were scanned and each spot of 203 
the image was quantified in terms of integrated optical densities (IOD) with ImageJ 204 
software (a public domain, Java-based image processing program developed at the 205 
National Institute of Health). Calibration curves were constructed by applying standards 206 
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to each plate in the range of 1-4 µg/µL to quantify the PLs. These values were related to 207 
the dry weight of cells and expressed as a percentage of the total PLs extracted. 208 
 209 
2.7 Yeast neutral lipid (NL) composition by thin-layer chromatography (TLC)    210 
NL composition of yeast was separated by one-dimensional TLC on silica gel 60F254 211 
(10 x 20 cm, 250 µm) (Merck, Germany). The plate was developed in three steps: the 212 
first step with hexane, tert-Butyl methyl ether (MTBE) and glacial acetic acid (50:50:2) 213 
to 35mm, the second step with hexane, tert-Butyl methyl ether (MTBE) and glacial 214 
acetic acid (80:20:1) to 60mm and the last step with hexane to 85mm. The standard 215 
lipids lanosterol, ergosterol, squalene, cholesteryl oleate, ethyl oleate, diolein, triolein 216 
were purchased from Sigma and were applied to every plate in the range of 1-4 µg/µL. 217 
After TLC, lipids were charred with 10% CuSO4 in 8% H3PO4 and heated to 160 ºC for 218 
4 min on a TLC Plate Heater (CAMAG). Plates were scanned and each spot of the 219 
image was quantified as integrated optical densities (IOS) with ImageJ software (a 220 
public domain, Java-based image processing program developed at the National 221 
Institute of Health). Calibration curves were constructed by applying standards to each 222 
plate in the range of 1-4 µg/µL to quantify the NLs. These values were related to the 223 
cell dry weight and expressed as a percentage of total NLs extracted. 224 
 225 
2.8 Determination of total yeast fatty acids 226 
Yeast cells (5-10 mg dry mass) were placed in sealed tubes with a Teflon-lined screw 227 
cap and saponified  using a 1 mL of 5% NaOH in 50% methanol/water (Rozès et al., 228 
1992). The tubes were placed in a dry bath (100 ºC) for 5 minutes. Samples were 229 
vortexed and then the tubes were placed in a dry bath (100 ºC) for another 25 minutes. 230 
Then the saponified material was cooled to room temperature and 2 mL HCl 6M was 231 
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added. Free fatty acids were extracted by adding 500 µL hexane: tert-Butyl methyl ether 232 
(MTBE) (1:1, v/v). Each tube was vortexed twice for 30 seconds. The organic phase 233 
was collected after centrifugation at 3000 rpm for 3 minutes. 234 
Analytical gas chromatography was performed on a Hewlett-Packard 6850 (Agilent 235 
Technologies). 1µL of cellular extract was injected (splitless, 1 minute) into a FFAP-HP 236 
column (30m x 0,25mm x 0.25µm from Agilent) with an HP 6850 automatic injector. 237 
The initial temperature was set at 140 ºC and increased by 4 ºC/min up to 240 ºC. 238 
Injector and detector temperatures were 250 ºC and 280 ºC, respectively. The carrier gas 239 
(helium) was at a flow rate 1.4 mL/min. Heptanoic and heptadecanoic acids (10 and 40 240 
mg/mL, respectively) were added as internal standards before cell saponification. 241 
Relative amounts of fatty acids were calculated from their respective chromatographic 242 
peaks. These values were related to the dry weight of cells and expressed as a 243 
percentage of the total fatty acid extracted (Redón et al., 2009). 244 
 245 
2.9 Statistical data processing 246 
All experiments were repeated at least three times, and data are reported as the mean 247 
value ± SD. Significant differences between the control strain, the mutant and the 248 
overexpressing strains were determined by t-tests (SPSS 13 software package). The 249 
statistical level of significance was set at P ≤ 0.05. Principal component analysis (PCA) 250 
was done using vegan package (rda function) from the statistical software R v.2.15 (R 251 
Development Core Team, 2010). 252 
 253 
3. Results 254 
3.1 Generation time (GT) 255 
3.1.1 Determination of generation time and spot test in BY4742 lipid mutants 256 
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In order to determine the importance of lipid metabolism genes on growth at low 257 
temperature, we determined GT and carried out spot test for the screening of the 258 
BY4742 lipid mutants at 12 ºC and at 28 ºC. Most of the deleted genes analyzed (some 259 
deletions produce unviable phenotypes) are shown graphically in their respective 260 
pathways (Fig. 1). The GT of these mutant strains is also grouped on the basis of the 261 
biosynthesis pathway to which they belong (phospholipids, sterols and sphingolipids) 262 
(Fig. 2).   263 
The strains with deletions in the genes OPI3, CHO2 and PSD1, encoding enzymes of 264 
the phospholipid pathway; ERG24, ERG6 and ERG3, from the sterol biosynthesis 265 
pathway; and DPL1, involved in sphingolipid pathway significantly increased their GT 266 
at 12 ºC compared to the control strain BY4742. Some of these mutant strains also 267 
showed significant differences at 28 ºC, but, most of them, these were not as extreme as 268 
at 12 ºC (Fig. 2).  269 
Conversely, some mutant strains improved their relative growth. A remarkable decrease 270 
in GT was detected for the deletion of ERG2, involved in the synthesis of a precursor of 271 
ergosterol (episterol). Likewise, several mutant strains of the sphingolipid synthesis, 272 
such as ysr3, csg2, ipt1, sur2, ydc1, lcb4 and lcb3, also decreased their GT 273 
significantly compared to control strain BY4742. 274 
This data on growth in liquid SC were corroborated by a drop test on a SC agar plate at 275 
12 ºC and 28 ºC. Generally, the same mutant strains also showed an impaired growth at 276 
low temperature whereas they were hardly affected at 28 ºC.  As an example, the drop 277 
test for the ERG genes (ergosterol pathway) is shown in Figure 2D.  Only the deletion 278 
of cardiolipin synthesis (CRD1) led to worse growth on solid medium than in liquid 279 
medium at 12 ºC (data no shown). 280 
 281 
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3.1.2 Determination of generation time in lipid mutants and overexpressing strains of 282 
hoQA23 283 
A total of 15 genes, whose deletion showed significant differences in GT in BY4742, 284 
were also deleted in the haploid wine strain hoQA23. The first remarkable result was 285 
the difference in growth behavior observed depending on the genetic background of the 286 
strains in which the genes were deleted. In contrast to the laboratory strain, no deletion 287 
yielded better growth than the parental wine strain hoQA23 (Fig. 3A). Most of the 288 
deleted genes from the sphingolipid pathway with a lower GT in BY4742 mutants did 289 
not show differences or displayed slow growth (i.e. lcb3) in the hoQA23. Other 290 
remarkable differences between both strains were the phenotypes observed for the 291 
mutant strains of genes CHO2 and CRD1 in the wine strain hoQA23. The cho2 strain 292 
was unable to grow in SC medium (only grew in YPD) but growth was recovered when 293 
SC medium was supplemented with choline. Thus the mutation of this gene caused 294 
auxotrophy for choline in the wine strain hoQA23. Regarding CRD1, we were unable to 295 
delete this gene in hoQA23 because the CRD1 knock-out made this strain unviable. We 296 
confirmed that CRD1 is required for viability of this wine strain by further deleting one 297 
of the copies of the diploid commercial strain QA23. This heterozygous mutant strain 298 
(CRD1/crd1) was sporulated but only the spores of the wild copy (non Geneticin 299 
resistant) were recovered in the YPD medium. The heterozygous mutant strain 300 
(CRD1/crd1) did not show any differences in terms of GT with the parental strain 301 
QA23 (data not shown). Thus this mutation produces unviability but not 302 
haploinsufficiency.  303 
The mutant strains with significant differences in GT are shown in Figure 3A. erg3, 304 
psd1 and opi3 showed the most important increases in GT. These two latter 305 
 14 
phospholipid mutants also presented impaired growth at 28 ºC, but, as in the case of 306 
BY4742, these increases in GT were much more moderate than at low temperature.  307 
The six genes whose deletion produced slowest growth were also overexpressed in the 308 
wine strain hoQA23. Although lcb4 did not show significant differences in GT, we 309 
decided to overexpress this gene because it encodes the enzyme Lcb4, a sphingoid long-310 
chain base kinase, which catalyzes the reversible step of Lcb3, and has been related with 311 
heat shock adaptation (Dickson et al., 2006). We also constructed strains 312 
overexpressing genes IDI1 and OLE1, whose deletion produced an unviable phenotype 313 
(Giaever et al., 2002) and CHO2, whose knock-out also yielded an auxotrophic 314 
phenotype for choline. IDI1 is involved in the ergosterol biosynthesis pathway (Fig. 1) 315 
and OLE1 encodes the only desaturase in S. cerevisiae, required for monounsaturated 316 
fatty acid synthesis (Mitchell and Martin, 1995). The overexpression of the selected 317 
genes decreased GT at low temperature, although only the strains pGREG LCB3, 318 
pGREG IDI1, pGREG ERG3, pGREG OPI3 and pGREG PSD1 showed significant 319 
decreases in GT (Fig. 3B).  320 
 321 
3.2 Lipid composition 322 
The lipid composition (fatty acids, phospholipids, neutral lipids and sterols) of the 323 
mutant and overexpressing strains selected in the previous section was compared with 324 
the control strains (hoQA23 and hoQA23 pGREG). It is worth mentioning that TLC 325 
enables us to detect only the main metabolites of the phospholipid and ergosterol 326 
biosynthesis pathways. Unfortunately we were not able to analyze sphingolipids with 327 
the methodology available in our laboratory. The percentages of the different lipids in 328 
the constructed strains are shown in Table S1. The impact of deleting or overexpressing 329 
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a gene on the compounds of its respective pathway is graphically shown in Figures 4 330 
and 5. 331 
As expected, the most important modification in phospholipid composition was 332 
observed in the mutant strains of phospholipid pathway psd1 and opi3, which 333 
showed a significant increase in PI and important reduction of PS, PC and PE (Fig. 4 334 
A.1). In fact, PE and PC were not detected in psd1 and opi3 respectively. Moreover, 335 
the blockage in PC synthesis in opi3 yielded a new band on HPLTC plates, which may 336 
suggest the detection of PMPE and PMMPE intermediates (Fig. 1A). For psd1, the 337 
strong PE reduction seemed to be compensated by a significant increase in CL (Fig. 4 338 
A.1). It should be kept in mind that we cannot analyze PL composition of cho2 339 
because this mutant was unable to grow in SC medium. 340 
It should be highlighted that the parental hoQA23 (control strain of the mutants; panel 341 
1) and the same strain transformed with the empty vector pGREG (control strain of the 342 
overexpressing strains; panel 2) differed in the composition of some PLs. These 343 
differences may be explained by the presence of Geneticin in the growth medium of the 344 
overexpressing strains and resistance to this antibiotic encoded in the plasmid. For all 345 
the phospholipid overexpressing strains, the most important changes were observed in 346 
pGREG CHO2 (Fig. 4 A.2). Contrary to the expected result, overexpression of CHO2 347 
induced a significant increase in PE and CL percentages, but a decrease in PC. In fact, 348 
most of the overexpressing strains showing significant differences seemed to follow the 349 
same trend: to decrease their PC content and increase in PE and CL percentage, except 350 
pGREG OLE1 and pGREG DPL1 which had less PE (Table S1).  351 
In contrast to PL composition, the mutant and overexpressing strains involved in sterol 352 
synthesis did not show important changes in sterol composition (Fig. 4 B.1 and 4 B.2). 353 
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The most remarkable trend is that the overexpressing strains increased the sterol esters 354 
and decreased squalene. 355 
As expected, pGREG OLE1 significantly increased UFA (mainly in palmitoleic acid 356 
C16:1) and decreased saturated fatty acids (SFA) (mainly in palmitic acid C16) (Fig. 5). 357 
However most of the overexpressing strains which showed significant differences in 358 
their GT (pGREG OPI3, pGREG IDI1 and pGREG LCB3) also significantly increased 359 
the UFA/SFA ratio (Table S1). In the case of the mutant strains, the general trend was 360 
an increase in C16 and C16:1 and a decrease in C18 and C18:1. This increase in shorter-361 
chain fatty acids resulted in a decrease in the average fatty acid chain length of most of 362 
the mutant strains. As a paradigm of this trend, we were able to detect the myristoleic 363 
acid (C14:1) in erg6 whereas C18 was undetectable in lcb3 (Table S1). 364 
 365 
3.3 Principal component analysis (PCA) 366 
In order to explore the effect of the deletion and overexpression of the target genes in 367 
lipid composition, a PCA was performed on the 19 strains using the untransformed 368 
relative concentration of the 18 compounds measured in all strains (Fig. 6). The two 369 
first components were retained explaining 80.8% of the total variance. The first 370 
component explained 66.2% of the variation and was marked by high positive 371 
component loadings for sterol esters (+0.605) and PC (+0.430) and high negative 372 
loadings for PI (-0.429) and FA (-0.406). The second component explained 14.6% of 373 
the variation and was marked by high positive component loadings for sterol esters 374 
(+0.620) and PI (+0.511) and high negative loadings for PE (-0.395) and TG (-0.320). 375 
The general pattern provided by the PCA is the formation of two groups: deletion and 376 
overexpressing strains associated with low and high amounts of sterol esters, 377 
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respectively. Moreover deletion strains were grouped by PI content and overexpressing 378 
strains by PE content. 379 
 380 
4. Discussion  381 
Yeast adaptation at low temperature is an interesting feature from an industrial 382 
viewpoint, especially in the wine industry, where low temperatures are used to enhance 383 
production and retain flavor volatiles. Lipid composition of the cellular membranes has 384 
been directly related with yeast adaptive response at different environmental 385 
temperatures in many studies (Beltran et al., 2008; Henschke and Rose, 1991; Redón et 386 
al., 2011; Torija et al., 2003). A possible adaptation might be the reshaping of the 387 
plasma membrane composition, which would reduce the lag phase, increase growth and 388 
speedup fermentation onset. In a previous study, we modified lipid composition by 389 
incubating yeast cells in the presence of different lipid compounds, improving growth 390 
and fermentation activity at low temperature (Redón et al., 2009). Another strategy to 391 
redesign the cellular lipid composition is to alter transcriptional activity by deleting or 392 
overexpressing key genes of lipid metabolism. This latter strategy has previously been 393 
and successfully assayed, though not as comprehensively as in this study. Some authors 394 
have overexpressed the gene encoding the S. cerevisiae desaturase OLE1 (Kajiwara et 395 
al., 2000) or other heterologous desaturases (Rodríguez-Vargas et al., 2006) in order to 396 
increase the degree of unsaturation and membrane fluidity, while improving the cold 397 
resistance of these engineered strains. In a recent work (Redón et al., 2012), we have 398 
also detected an improved or impaired fermentation vitality in some mutants of the 399 
phospholipid biosynthesis. In the present study, we have screened most of the mutants 400 
of the laboratory strain BY4742 encoding enzymes of the phospholipid, sterol and 401 
sphingolipid pathways in terms of their growth capacity at low temperature. The GT of 402 
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these mutant strains was used to select genes which were further deleted in a derivative 403 
industrial strain. Again, the deleted genes showing impaired growth at low temperature 404 
were overexpressed in the genetic background of this industrial strain. The main 405 
objective of this study was to identify lipid-metabolism genes that play a key role in the 406 
adaptive response of wine yeast to low temperature and to verify the correlation 407 
between growth at low temperature and lipid composition. 408 
Phenotypic differences between strains mutated in the same gene constructed in the 409 
laboratory and wine yeast showed the importance of the genetic background (Pizarro et 410 
al., 2008; Redón et al., 2011). In the wine strain hoQA23, the deletion of CRD1 led to 411 
unviability whereas BY4742 was hardly affected by the deletion of this gene. CRD1 412 
encodes cardiolipin synthase which catalyses the last step in CL synthesis, but it is not 413 
essential for growth (Breslow et al., 2008). Thus, other complementary mutations 414 
confer synthetic lethality in the haploid wine strain hoQA23. ERG24 provides another 415 
example of the genetic background effect. This gene encodes a C-14 sterol reductase 416 
and the mutants accumulate the abnormal sterol ignosterol (ergosta-8,14 dienol), and are 417 
viable under anaerobic growth conditions but unviable on rich medium under aerobic 418 
conditions (Marcireau et al., 1992). We detected important impaired growth in the 419 
BY4742 erg24, although this mutation hardly affected growth fitness in hoQA23. 420 
However, in spite of these differences, we detected gene deletions which significantly 421 
affected growth fitness at low temperature in both studied strains.  422 
The mutants in the PL synthesis pathway psd1 and opi3 (and cho2 in the BY4742) 423 
showed the greatest increases in terms of GT in comparison with the parental strains. 424 
These genes encode the enzymes involved in synthesis of the most important plasma 425 
membrane phospholipids, PE and PC, by the de novo pathway (Daum et al., 1998). As 426 
expected, these mutant strains were characterized by a strong reduction in the 427 
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proportion of PE and PC. S. cerevisiae had two PS-decarboxylases, one located in the 428 
mitochondrial inner membrane (encoded by PSD1) and another located in the Golgi and 429 
vacuolar membranes (encoded by PSD2). Daum et al. (1998) reported PSD1 had no 430 
effect on cell viability because psd1 had residual PSD activity attributed to Psd2p.  431 
However the presence of the isoenzyme Psd2p was not enough to counterbalance the 432 
lack of Psd1p growing at low temperature. The decrease in PE and PC in the psd1 and 433 
opi3 strains was counterbalanced by the increase in PI and CL. All these PLs have the 434 
same precursor CDP-DAG and, the blockage in the PE and PC biosynthetic branch 435 
increased the flux in the other two branches, leading to PI and CL increases (Fig. 1A). 436 
Contrary to PL mutant strains, the overexpression of genes OPI3 and PSD1 produced a 437 
significant reduction in GT in the wine strain at low temperatures. Enhanced growth in 438 
the PL overexpressing strains could be correlated with changes in lipid composition; 439 
however, these overexpressing strains did not significantly increase PE and PC. Even 440 
the overexpression of OPI3, which catalyzes the last two steps in PC biosynthesis, 441 
decreased the proportion of this PL. This metabolic route must be fine-tuned to avoid 442 
imbalances in PL proportion as a consequence of increasing the gene-dosage of some 443 
enzymes in the pathway.  444 
The deletion and overexpression of ERG3 also produced a phenotype with worse and 445 
better growth, respectively, in comparison with the parental strain. This gene encodes a 446 
sterol desaturase, which catalyzes the insertion of a double bond into episterol, a 447 
precursor in ergosterol biosynthesis. The deletion of this gene has previously been 448 
related with cold sensitivity (Hemmi et al., 1995). These authors correlated the growth 449 
defect at low temperature with a defect in tryptophan uptake in the erg3 mutants. 450 
Another overexpressed gene in the ergosterol pathway that significantly reduced its 451 
duplication time was IDI1 (mutant strain is unviable). We selected this gene because 452 
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Beltran et al. (2006) previously reported a strong up-regulation of this gene at low 453 
temperature fermentation in a global transcriptomic analysis of the same industrial wine 454 
yeast. IDI1 encodes the isopentenyl-diphosphate delta-isomerase which catalyzes the 455 
isomerization between isopentenyl pyrophosphate and dimethylallyl pyrophosphate 456 
(Fig. 1B). In terms of sterol composition, the overexpression of this gene did not change 457 
the proportion of the main sterols substantially. As in the PL overexpressing strains, it is 458 
difficult to correlate improved growth with changes in the composition of the main 459 
metabolites of the pathways involving these genes. It must be borne in mind that our 460 
methodology was unable to detect ergosterol precursors. Thus, the possibility that 461 
deletion or overexpression may produce changes in the concentration of these 462 
precursors cannot be ruled out.  463 
Finally, only the mutation and overexpression of the sphingolipid gene LCB3 yielded a 464 
significant increase and decrease, respectively, in GT. This gene encodes a phosphatase 465 
with specificity for dihydrosphingosine-1-phosphate, regulating ceramide and long-466 
chain base phosphate levels and involves in incorporation of exogenous long-chain 467 
bases in sphingolipids (Mao et al., 1997; Mandala et al., 1998; Qie et al., 1997). 468 
Intermediates in sphingolipid biosynthesis, such as sphingolipid long-chain bases 469 
(LCBs), dihydrosphingosine (DHS) and phytosphingosine (PHS) (Figure 1C), have 470 
been identified as secondary messengers in signaling pathways that regulate the heat 471 
stress response (Ferguson-Yankey et al.,  2002; Jenkins et al., 1997). Thus, it cannot be 472 
ruled out that these sphingolipid intermediates may also contribute to the cold stress 473 
response. Unfortunately we were not able to determine how the deletion or 474 
overexpression of this gene affected the content of these intermediates.  475 
In an attempt to correlate growth of the different constructed strains at low temperature 476 
and modification in their lipid composition, we performed a PCA. This is a useful tool 477 
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for identifying similarity and difference patterns among strains for which many data are 478 
analyzed. The PCA data clearly separated the mutant strains (left panel) from the 479 
overexpressing strains (right panel). Although genes involved in different lipid 480 
pathways were deleted or overexpressed, a general modification of the lipid profile can 481 
be ascribed to both groups of strains. The mutant strains tended to increase PI and FA, 482 
whereas the overexpressing strains increased sterol esters and the phospholipids PC and 483 
PE. Both lipid compounds have been linked to low temperature growth or fermentation 484 
activity in previous works by our research team. Redon et al. (2011) compared the lipid 485 
composition of strains, belonging to different Saccharomyces species and isolated from 486 
different fermentative processes (wine, beer, bread), after growing at optimum (25 ºC) 487 
and low temperatures (13 ºC). A common change in all the strains under study was the 488 
increase in PE and reduction in the PC/PE ratio. In a similar study, Tronchoni et al. 489 
(2012) also compared the lipid composition of different S. kudriavzevii strains (a more 490 
psychrophilic species than S. cerevisiae) and hybrid strains between S. cerevisiae and S. 491 
kudriavzevii. In these strains, in terms of neutral lipids, a common response to low 492 
temperature was an increase in TG and SE, the main storage lipids.  These storage lipids 493 
are mainly synthesized during the stationary phase, when the growth is arrested, and 494 
there is an excess of intermediates of the biosynthetic pathways (Czabany et al., 2007), 495 
in a similar manner to the accumulation of carbohydrates such as glycogen and 496 
trehalose. Thus, the excess of intermediates of the sterol pathway in the overexpressing 497 
strains can produce an increase in the synthesis of sterol esters. 498 
In conclusion, here we report a study aiming to detect the role of key lipid metabolism 499 
genes in promoting better growth at low temperature and which can be important in the 500 
adaptation to industrial processes. The study has identified genes involved in the 501 
phospholipid (PSD1 and OPI3), sterol (ERG3 and IDI1) and sphingolipid (LCB3) 502 
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pathways whose deletion strongly impaired growth at low temperature, whereas their 503 
overexpression reduced generation or division time by almost half. The study also 504 
reveals the importance of constructing mutant and overexpressing strains in the genetic 505 
background of commercial wine yeast, given the many phenotypic differences observed 506 
between these and the laboratory strain. As the impact of all these genes can be 507 
modulated by the genetic background, new strains should be tested in future studies to 508 
ensure the universality of these mechanisms of adaptation at low temperature. 509 
Moreover, further research will test these strains with improved growth during grape 510 
must fermentations and analyze their growth behavior and fermentation performance. 511 
This information may help to improve the future performance of wine yeast at low 512 
temperature, either by genetic modification or by the selection of strains with a better 513 
genetic makeup in terms of low temperature adaptation. 514 
 515 
Acknowledgments 516 
This work was financially supported by the grants from the Spanish government 517 
(projects AGL2010-22001-C02-02 and AGL2010-22001-C02-01, awarded to NR and 518 
JMG, respectively). MLM also wants to thank to Spanish government for her FPI grant.  519 
 520 
References 521 
Aguilera, J., Randez-Gil, F., Prieto, J.A., 2007. Cold response in Saccharomyces 522 
cerevisiae: new functions for old mechanisms. FEMS Microbiology Reviews 31, 327–523 
341. 524 
Beltran, G., Novo, M., Leberre, V., Sokol, S., Labourdette, D., Guillamon, J.M., Mas, 525 
A., François, J., Rozès, N., 2006. Integration of transcriptomic and metabolic analyses 526 
 23 
for understanding the global responses of low-temperature winemaking fermentations. 527 
FEMS Yeast Research 6, 1167–1183. 528 
Beltran, G., Rozès, N., Mas, A., Guillamón J.M., 2007. Effect of low-temperature 529 
fermentation on yeast nitrogen metabolism. World Journal of Microbiology and 530 
Biotechnology 23, 809–815. 531 
Beltran, G., Novo, M., Guillamón, J.M., Mas, A., Rozès, N., 2008. Effect of 532 
fermentation temperature and culture media on the yeast lipid composition and wine 533 
volatile compounds. International Journal of Food Microbiology 121, 169–177. 534 
Bisson, L., 1999. Stuck and sluggish fermentations. American Journal of Enology 535 
Viticulture 50, 107–109.  536 
Breslow, D.K., Cameron, D.M., Collins, S.R., Schuldiner, M., Stewart-Ornstein, J., 537 
Newman, H.W., Braun, S., Madhani, H.D., Krogan, N.J., Weissman, J.S., 2008. A 538 
comprehensive strategy enabling high-resolution functional analysis of the yeast 539 
genome. Nature Methods 5, 711–718.  540 
Czabany, T., Athenstaedt, K., Daum, G., 2007. Synthesis, storage and degradation of 541 
neutral lipids in yeast. Biochimica et Biophysica Acta 2007, 299–309. 542 
Daum, G., Lees, N.D., Bard, M., Dickson, R., 1998. Biochemistry, cell biology and 543 
biology of lipids of Saccharomyces cerevisiae. Yeast 14, 1471–1510. 544 
Dickson, R.C., Sumanasekera, C., Lester, R.L., 2006. Functions and metabolism of 545 
sphingolipids in Saccharomyces cerevisiae. Progress in Lipid Research 45, 447–467. 546 
 24 
Ferguson-Yankey, S.R., Skrzypek, M.S., Lester, R.L., Dickson, R.C., 2002. Mutant 547 
analysis reveals complex regulation of sphingolipid long chain base phosphates and 548 
long chain bases during heat stress in yeast. Yeast 19, 573-86. 549 
Giaever, G., Chu, A.M., Ni, L., et al 2002. Functional profiling of the Saccharomyces 550 
cerevisiae genome. Nature 418, 387-391. 551 
 Gietz, R.D., Woods, R.A., 2002. Transformation of yeast by lithium acetate/single-552 
stranded carrier DNA/polyethylene glycol method. Methods in Enzymology 350, 87–96. 553 
Güldener, U., Heck, S., Fiedler, T., Beinhauer, J., Hegemann, J.H., 1996. A new 554 
efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids 555 
Research 24, 2519–2524. 556 
Hemmi, K., Julmanop, C., Hirata, D., Tsuchiya, E., Takemoto, J.Y., Miyakawa, T., 557 
1995. The physiological roles of membrane ergosterol as revealed by phenotypes 558 
syr1/erg3 null mutant of Saccharomyces cerevisiae. Bioscience, Biotechnology and 559 
Biochemistry 59, 482–486.  560 
Henschke, P.A., Rose, A.H., 1991. Plasma membrane. The yeasts, Vol. IV: Yeast 561 
Organelles (Rose AH and Harrison JS, eds), pp. 297-345. Academic Press Limited, 562 
London, UK. 563 
Homma, T., Iwahashi, H., Komatsu, Y., 2003. Yeast gene expression during growth at 564 
low temperature. Cryobiology 46, 230–237.  565 
Hunter, K., Rose, A.R., 1972. Lipid composition of Saccharomyces cerevisiae as 566 
influenced by growth temperature. Biochimica et Biophysica Acta 260, 639–653. 567 
 25 
 Jansen, G., Wu, C., Schade, B., Thomas, D.Y., Whiteway, M., 2005. Drag and Drop 568 
cloning in yeast. Gene 344, 43–51. 569 
Jenkins, G.M., Richards, A., Wahl, T., Mao, C., Obeid, L., Hannun, Y., 1997.  570 
Involvement of yeast sphingolipids in the heat stress response of Saccharomyces 571 
cerevisiae. The Journal of Biological Chemisty 272, 32566–72. 572 
Kajiwara, S., Aritomi, T., Suga, K., Ohtaguchi, K., Kobayashi, O., 2000. 573 
Overexpression of the OLE1 gene enhances ethanol fermentation by Saccharomyces 574 
cerevisiae. Applied Microbiology and Biotechnololgy 53, 568–574. 575 
Mandala, S.M., Thornton, R., Tu, Z., Kurtz, M.B., Nickels, J., Broach, J., Menzeleev, 576 
R., Spiegel, S., 1998. Sphingoid base 1-phosphate phosphatise: A key regulator of 577 
sphingolipid metabolism and stress response. Cell Biology 95, 150–155. 578 
Mao, C., Wadleigh, M., Jenkins, G.M., Hannun, Y.A., Obeid, L.M., 1997. Identification 579 
and characterization of Saccharomyces cerevisiae dihydrosphingosine-1-phosphate 580 
phosphatase. The Journal of Biological Chemistry 272, 28690–28694. 581 
Marcireau, C., Guyonnet, D., Karst, F., 1992. Construction and growth properties of a 582 
yeast strain defective in sterol 14-reductase. Current Genetics 22, 267–272. 583 
Meurgues, O., 1996. La valorisation del arômes du Chardonnay en Bourgogne par les 584 
techiques de vinification. Revue Française d’Oenologie 160, 43–45. 585 
Mitchell, A.G., Martin, C.E., 1995. A novel cytochrome b5-like domain is linked to the 586 
carboxyl terminus of the Saccharomyces cerevisiae delta-9 fatty acid desaturase. The 587 
Journal of Biological Chemistry 270, 29766–72. 588 
 26 
 Murata, Y., Homma, T., Kitagawa, E., Momose, Y., Sato, M.S., Odani, M., Shimizu, 589 
H., Hasegawa-Mizusawa, M., Matsumoto, R., Mizukami, S., Fujita, K., Parveen, M., 590 
Komatsu, Y., Iwahashi, H., 2006. Genome-wide expression analysis of yeast response 591 
during exposure to 4°C. Extremophiles 10, 117–128. 592 
 Pizarro, F.J., Jewett, M.C., Nielsen, J., Agosin, E., 2008. Growth temperature exerts 593 
differential physiological and transcriptional responses in laboratory and wine strains of 594 
Saccharomyces cerevisiae. Applied and Environmental Microbiology 74, 6358–6368. 595 
Qie, L., Nagiec, M.M., Baltisbergier, J.A., Lester, R.L., Dickson, R.C., 1997.  596 
Identification of a Saccharomyces gene, LCB3, necessary for incorporation of 597 
exogenous long chain bases into sphingolipids. The Journal of Biological Chemistry 598 
272, 16110–16117. 599 
Redón, M., Guillamón, J.M., Mas, A., Rozès, N., 2009. Effect of lipids supplementation 600 
upon Saccharomyces cerevisiae lipid composition and fermentation performance at low 601 
temperature. European Food Research and Technology 228, 833–840. 602 
Redón, M., Guillamón, J.M., Mas, A., Rozès, N., 2011. Effect of growth temperature on 603 
yeast lipid composition and alcoholic fermentation at low temperature. European Food 604 
Research and Technology 232, 517–527. 605 
Redón, M., Borrull, A., López, M., Salvadó, Z., Cordero, R., Mas, A., Guillamón, J.M., 606 
Rozès, N., 2012. Effect of low temperature upon vitality of Saccharomyces cerevisiae 607 
phospholipid mutants. Yeast doi:10.1002/yea.2924. 608 
Robzyk, K., Kassir, Y., 1992. A simple and highly efficient procedure for rescuing 609 
autonomous plasmids from yeast. Nucleic Acids Research 20, 3790. 610 
 27 
Rodríguez-Vargas, S., Sánchez-García, A., Martínez-Rivas, J.M., Prieto, J.A.,  Randez-611 
Gil, F., 2006. Fluidization of membrane lipids enhances the tolerance of Saccharomyces 612 
cerevisiae to freezing and salt stress. Applied and Environmental Microbiology 73, 110-613 
6. 614 
Rozès, N., Garcia-Jares, C., Larue, F., Lonvaud-Funel, A., 1992. Differentiation 615 
between fermentating and spoiliage yeast in wine by total free fatty acid analysis. 616 
Journal of Science of Food and Agriculture 59, 351–359. 617 
Russell, N., 1990. Cold adaptation of microorganisms. Philosophical Translations of the 618 
Royal Society of London 326, 595–611. 619 
Sahara, T., Goda, T., Ohgiya, S., 2002. Comprehensive expression analysis of time-620 
dependent genetic responses in yeast cells to low temperature. The Journal of Biological 621 
Chemistry 277, 50010–50021. 622 
Salvadó, Z., Arroyo-López, F.N., Guillamón, J.M., Salazar, G., Querol, A., Barrio, E., 623 
2011. Temperature adaptation markedly determines the growth and evolution within the 624 
genus Saccharomyces. Applied and Environmental Microbiology 77, 2292–2302. 625 
Salvadó, Z., Chiva, R., Rozès, N., Cordero-Otero, R., Guillamón, J.M., 2012. 626 
Functional analysis to identified genes in wine yeast adaptation to low-temperature 627 
fermentation. Journal of Applied Microbiology doi:10.1111/j.1365-2672.2012.05308.x. 628 
Schade, B., Jansen, G., Whiteway, M., Entian, K.D., Thomas, D.Y., 2004. Cold 629 
adaptation in budding yeast. Molecular Biology of the Cell 15, 5492–5502. 630 
 28 
Tai, S.L., Daran-Lapujade, P., Walsh, M.C., Pronk, J.T., Daran, J., 2007. Acclimation of 631 
Saccharomyces cerevisiae to low temperature: A chemostat-based transcriptome 632 
analysis. Molecular Biology of the Cell 18, 5100–5112. 633 
Torija, M.J., Beltran, G., Novo, M., Poblet, M., Guillamón, J.M., Mas, A., Rozès, N., 634 
2003. Effects of fermentation temperature and Saccharomyces species on the cell fatty 635 
acid composition and presence of volatile compounds. International Journal of Food 636 
Microbiology 85, 127–136. 637 
Tronchoni, J., Rozès, N., Querol, A., Guillamón, J.M., 2012. Lipid composition of wine 638 
strains Sacharomyces kudriavzevii and Sacharomyces cereviasiae grown at low 639 
temperature. International Journal of Food Microbiology 155, 191–198. 640 
Zwietering, M.H., Jongerburger, I., Rombouts, F.M., Van’t Riet, K., 1990. Modeling of 641 
the bacteria growth curve. Applied and Environmental Microbiology 56, 1875–1881. 642 
 643 
Table 1. Strains constructed in this study 
 
Strain Genotype Definition 
hoQA23 MATα; YDL227C::kanMX4 Derivative wine haploid strain 
psd1 hoQA23; YNL169c::kanMX4 PSD1 mutant strain 
opi3 hoQA23; YJR073C::kanMX4 OPI3 mutant strain 
erg3 hoQA23; YLR056W::kanMX4 ERG3 mutant strain 
erg6 hoQA23; YML008C::kanMX4 ERG6 mutant strain 
lcb3 hoQA23; YJL134W::kanMX4 LCB3 mutant strain 
lcb4 hoQA23; YOR171C::kanMX4 LCB4 mutant strain 
dpl1 hoQA23; YDR294C::kanMX4 DPL1 mutant strain 
hoQA23 pGREG hoQA23-pGREG505 Haploid strain with empty plasmid  
pGREG PSD1 hoQA23-pGREG PSD1 PSD1 overexpressing strain 
pGREG CHO2 hoQA23-pGREG CHO2 CHO2 overexpressing strain 
pGREG OPI3 hoQA23-pGREG OPI3 OPI3 overexpressing strain 
pGREG ERG3 hoQA23-pGREG ERG3 ERG3 overexpressing strain 
pGREG ERG6 hoQA23-pGREG ERG6 ERG6 overexpressing strain 
pGREG IDI1 hoQA23-pGREG IDI1 IDI1 overexpressing strain 
pGREG OLE1 hoQA23-pGREG OLE1 OLE1 overexpressing strain 
pGREG LCB3 hoQA23-pGREG LCB3 LCB3 overexpressing strain 
pGREG LCB4 hoQA23-pGREG LCB4 LCB4 overexpressing strain 
pGREG DPL1 hoQA23-pGREG DPL1 DPL1 overexpressing strain 
 
Figure
Table S1. Percentage of phospholipids (PI, PS, PC, PE, CL, PA and MM-PE), neutral lipids (DG and TG), sterols (squalene, lanosterol, 
ergosterol and sterol esters) and fatty acids (C14:1, C16, C16:1, C18 and C18:1) expressed as the mean ± SEM (standard error of the mean) of 
total cellular concentration of these compounds. *Significant differences compared with their respective control strains (hoQA23 and hoQA23 
pGREG).  
 
  
 
 
 
 PHOSPHOLIPIDS NEUTRAL LIPIDS 
Strains PI PS PC PE CL PA MM-PE DG TG 
hoQA23  17.89 ± 1.16 6.11 ± 0.86 33.70 ± 2.72 25.25 ± 1.47 12.82 ± 2.83 4.23 ± 0.42 - 20.46 ± 2.43 79.54 ± 2.43 
∆psd1  38.10 ± 2.56* 1.50 ± 0.61* 13.54 ± 4.34* - 39.05 ± 9.25* 7.81 ± 1.74* - 39.59 ± 1.19* 60.41 ± 1.19* 
∆opi3  59.86 ± 1.39* 0.94 ± 0.13* - 5.42 ±1.89* 10.23 ± 0.96 2.02 ± 0.43* 21.53 ± 1.39* 32.25 ± 8.07 67.75 ± 8.07 
∆erg3  12.49 ± 0.01* 4.66 ± 0.34* 28.34 ± 2.96 21.26 ± 3.97 18.45 ± 0.70* 14.80 ± 1.37* - 18.25 ± 4.38 81.75 ± 4.38 
∆erg6  19.72 ± 0.28 4.46 ± 0.63 20.65 ± 0.32* 17.84 ± 0.90* 27.69 ± 0.57* 9.65 ± 0.92* - 30.50 ± 6.66 69.50 ± 6.66 
∆dpl1  8.42 ± 2.11* 7.02 ± 0.19 39.74 ± 2.30* 23.38 ± 1.53 nq nq - 20.62 ± 1.08 79.38 ± 1.08 
∆lcb3  10.89 ± 5.47 7.24 ± 1.15 39.15 ± 4.69 26.28 ± 3.25 nq nq - 22.51 ± 4.54 77.49 ± 4.54 
∆lcb4  13.51 ± 1.03* 6.09 ± 0.41 41.94 ± 3.77* 20.70 ± 3.53 nq nq - 29.96 ± 1.84* 70.04 ± 1.84* 
hoQA23 pGREG  10.34 ± 1.27 6.78 ±  0.76 48.61 ±  3.12 22.16 ± 1.57 3.07 ± 2.79 9.04 ± 1.84 - 29.06 ± 2.67 70.94 ± 2.67 
pGREG PSD1  7.69 ± 0.61 7.31 ±  0.80 46.70 ±  3.25 27.30 ± 2.96 4.31 ± 0.36 6.70 ± 0.25 - 29.24 ± 2.43 70.76 ± 2.43 
pGREG OPI3   16.15 ± 4.32 7.64 ±  0.26 28.51 ±  3.46* 24.34 ± 3.69 20.25 ± 5.50 3.10 ± 0.68 - 44.46 ± 1.75* 55.54 ± 1.75* 
pGREG CHO2  3.46 ± 0.03* 8.85 ±  0.07* 35.79 ±  2.07* 31.98 ± 2.21* 18.30 ± 6.67* 3.25 ± 0 - 29.70 ± 4.70 70.30 ± 4.70 
pGREG ERG3  10.10 ± 0.55 6.87 ±  0.25 42.27 ±  6.42 19.58 ± 3.51 13.84 ± 1.68* 7.34 ± 0.42 - 31.53 ± 5.45 68.47 ± 5.45 
pGREG ERG6  15.73 ± 0.28* 6.38 ±  0.63 40.49 ±  5.74 30.58 ± 0.91 4.65 ± 0.57 2.17 ± 0.92* - 23.51 ± 4.25 76.49 ± 4.25 
pGREG IDI1  8.87 ± 3.27 5.05 ±  0.66* 40.55 ±  0.96* 28.39 ± 2.83* 4.05 ± 0.71 13.09 ± 0.87* - 21.83 ± 3.27 78.17 ± 3.27 
pGREG OLE1  23.01 ± 6.77* 8.00 ±  0.64 46.55 ±  4.90 6.41 ± 1.50* 9.91 ± 0.59* 6.11 ± 0.32 - 12.51 ± 0.27* 87.49 ± 0.27* 
pGREG DPL1  12.05 ± 1.79 8.82 ±  0.44 53.26 ±  2.99 9.96 ± 0.38* nq nq - 17.88 ± 3.63* 82.12 ± 3.63 
pGREG LCB3  3.16 ± 0.73* 5.24 ±  0.19* 36.63 ±  2.65* 41.48 ± 2.66* nq nq - 29.50 ± 3.67 70.50 ± 3.67 
pGREG LCB4  7.58 ± 0.00* 5.79 ±  0.33* 37.83 ±  3.92* 36.35 ± 9.85* nq nq - 30.80 ± 7.31 69.20 ± 7.31* 
(cont.) STEROLS FATTY ACIDS 
Strains Squalene Lanosterol Ergosterol Sterol esters C14:1 C16 C16:1 C18 C18:1 
hoQA23  6.69 ± 1.07 4.09 ± 0.69 30.80 ± 4.30 58.43 ± 4.68 - 13.62 ± 0.64 32.55 ± 0.19 3.66 ± 0.51 50.18 ± 0.90 
∆psd1  1.69 ± 0.09* 8.98 ± 0.25* 33.92 ± 2.28 55.41 ± 1.94 - 13.18 ± 0.88 33.07 ± 1.47* 6.57 ± 2.88 47.19  ± 2.60 
∆opi3  12.19 ± 3.95 25.00 ± 4.19* 36.86 ± 2.83 25.94 ± 6.16* - 16.53 ± 0.37* 43.44 ± 1.54 2.66 ± 2.35 37.37 ± 0.54* 
∆erg3  4.73 ± 1.08 5.36 ±  2.47 45.16 ± 5.55 44.74 ± 7.41 - 17.08 ±1.37* 41.92 ± 1.20* 3.23 ± 1.15 35.78 ± 1.43* 
∆erg6  10.15 ± 0.72 1.88 ± 2.62 45.78 ± 10.35 42.20 ± 13.69 12.39 ± 4.95* 15.22 ± 0.99 33.45 ± 1.73* 2.35 ± 0.37 34.61 ± 2.78* 
∆dpl1  4.19 ± 0.98 3.11 ± 0.65 34.46 ± 1.89 58.24 ± 2.06 - 17.93 ± 1.09* 35.14 ± 1.08* 3.78 ± 0.24 42.62 ± 0.15* 
∆lcb3  10.71 ± 3.03 2.85 ± 0.75 30.05 ± 3.07 56.39 ± 4.22 - 19.30 ± 3.31 41.62 ± 2.53* - 39.08 ± 0.78* 
∆lcb4  7.47 ± 2.95 3.60 ± 1.55 43.47 ± 3.49* 45.45 ± 3.01* - 22.06 ± 1.46* 37.37 ± 1.06* 2.22 ± 1.92 38.35 ± 2.48* 
hoQA23 pGREG  6.50 ± 1.08 - 15.95 ± 0.12 77.55 ± 1.20 - 22.53 ± 1.02 33.88 ± 1.70 5.37 ± 1.87 35.81 ± 1.09 
pGREG PSD1  9.59 ± 2.39 - 15.39 ± 3.06 75.02 ± 0.67 - 22.43 ± 0.93 32.89 ± 0.84 4.13 ± 0.10 38.24 ± 1.57 
pGREG OPI3   3.73 ± 0.67* 1.72 ± 0.11* 24.11 ± 1.21* 70.44 ± 1.99 - 17.65 ± 1.25* 41.50 ± 2.12* 1.05 ± 1.81* 39.81 ± 0.36* 
pGREG CHO2  3.69 ± 1.44 2.56 ± 0.90* 20.19 ± 4.31 73.57 ± 6.42 - 17.60 ± 0.87* 36.45 ± 1.07 3.31 ± 0.22 42.65 ± 0.03* 
pGREG ERG3  3.68 ± 0.48* 0.30 ± 0.16 12.95 ± 1.87 83.08 ± 1.94* - 17.11 ± 0.29* 37.19 ± 1.16* 3.34 ± 0.32 40.30 ± 1.62 
pGREG ERG6  2.85 ± 0.00* - 14.44 ± 2.03 82.71 ± 2.03 - 18.35 ± 0.99* 35.51 ± 0.67 3.12 ± 3.03 43.02 ± 2.83* 
pGREG IDI1  3.97 ± 0.32* - 11.26 ± 2.83 84.77 ± 2.88* - 20.29 ± 0.99* 36.47 ± 0.67* 3.31 ± 3.03 39.93 ± 2.83 
pGREG OLE1  4.61 ± 1.10 2.28 ± 0.52 13.14 ± 1.39 79.98 ± 3.02 - 12.25 ± 0.82* 41.93 ± 0.39* 3.95 ± 0.30 41.88 ± 1.36* 
pGREG DPL1  3.18 ± 0.60* 0.89 ± 0.12* 10.05 ± 0.46 85.87 ± 0.30* - 16.80 ± 0.34* 35.77 ± 1.74 3.96 ± 0.35 43.20 ± 1.39* 
pGREG LCB3  8.01 ± 2.52 9.34 ± 4.55 12.57 ± 1.70 70.08 ± 8.70 - 19.91 ± 0.34 36.37 ± 1.74 3.97 ± 0.35 39.75 ± 1.39* 
pGREG LCB4  1.90 ± 0.36* 2.23 ± 0.95 11.45 ± 1.89 84.42 ± 2.05* - 21.35 ± 0.44* 33.58 ± 2.41 5.06 ± 1.40 38.90 ±1.80* 
(-) not detected, (nq) not quantified 
 
 
 
Figure legends 
 
Figure 1. Diagrams of the major pathways for lipid biosynthesis in S. cerevisiae: A) 
Phospholipid pathway B) Sterol pathway C) Sphingolipid pathway. Genes in bold 
indicate viable mutants. 
 
Figure 2. Growth of lipid mutant strains compared with control strain BY4742. 
Generation time of A) phospholipid, B) sterol, C) sphingolipid mutants grown at 12 ºC 
(black bars) and at 28 ºC (grey bars). The GT of the mutant strains were compared to 
GT of control strain BY4742 (normalized as value 1). The duplication time for this 
control strain was 20.24 h at 12 ºC and 3.09 h at 28 ºC. D) Results of sterol mutants spot 
test at 12º C and 28 ºC. *Significant differences compared with the wild type at the 
same temperature. 
 
Figure 3. Growth of lipid mutant and overexpressing strains compared with their 
control strains. Generation time of A) mutant and B) overexpressing strains grown at 12 
ºC (black bars) and at 28 ºC (grey bars). The GT of the mutant and overexpressing 
strains compared to GT of their control strains hoQA23 and hoQA23 pGREG 
(normalized as value 1). The GT for control strains was the following: 15.94 h and 2.58 
h for hoQA23 and 12.18 h and 3.13 h for hoQA23 pGREG at 12 ºC and 28 ºC, 
respectively. *Significant differences compared with the control strains at the same 
temperature. 
 
Figure 4. Percentages of phospholipids (A), neutral lipids and sterols (B) for the mutant 
(1) and overexpressing (2) strains of these biosynthetic pathways. *Significant 
differences compared with their respective control strains. 
 
Figure 5. Percentages of fatty acids of pGREG OLE1 strain and their control strain, 
hoQA23 pGREG. *Significant differences compared with their respective control 
strains.  
 
Figure 6. Biplot of the first two components of the PCA according to the lipid 
composition. Variables are represented by grey underlining and samples are represented 
by black underlining: deletion strains (lower-case letters) and overexpressing strains 
(capital letters).   
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